Amphiregulin in lung branching morphogenesis: interaction with heparan sulfate proteoglycan modulates cell proliferation - PubMed (original) (raw)
. 1996 Jun;122(6):1759-67.
doi: 10.1242/dev.122.6.1759.
Affiliations
- PMID: 8674415
- DOI: 10.1242/dev.122.6.1759
Amphiregulin in lung branching morphogenesis: interaction with heparan sulfate proteoglycan modulates cell proliferation
L Schuger et al. Development. 1996 Jun.
Abstract
Epithelial and mesenchymal cells isolated from mouse embryonic lungs synthesized and responded to amphiregulin (AR) in a different fashion. Mesenchymal cells produced and deposited 3- to 4-fold more AR than epithelial cells, proliferated in the presence of exogenous AR, and their spontaneous growth was blocked by up to 85% by anti-AR antibodies. In contrast, epithelial cells exhibited a broad response to this growth regulator factor depending on whether they were supplemented with extracellular matrix (ECM) and whether this ECM was of epithelial or mesenchymal origin. AR-treated epithelial cells proliferated by up to 3-fold in the presence of mesenchymal-deposited ECM, remained unchanged in the presence of epithelial-deposited ECM, and decreased in their proliferation rate below controls in the absence of ECM supplementation. This effect was abolished by treatment with the glycosaminoglycan-degrading enzymes heparinase and heparitinase suggesting the specific involvement of heparan sulfate proteoglycan (HSPG) in AR-mediated cell proliferation. In whole lung explants, branching morphogenesis was inhibited by antibodies against the AR heparan sulfate binding site and stimulated by exogenous AR. Since during development, epithelial cells are in contact with mesenchymal ECM at the tips of the growing buds and alongside the basement membrane, focal variations in the proportion of epithelial and mesenchymal HSPG will focally affect epithelial proliferation rates. Therefore, AR-HSPG interaction may underlie the process of branching morphogenesis by inducing differential cell proliferation.
Similar articles
- Heparan sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor.
Johnson GR, Wong L. Johnson GR, et al. J Biol Chem. 1994 Oct 28;269(43):27149-54. J Biol Chem. 1994. PMID: 7929459 - Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors.
Bernfield M, Sanderson RD. Bernfield M, et al. Philos Trans R Soc Lond B Biol Sci. 1990 Mar 12;327(1239):171-86. doi: 10.1098/rstb.1990.0052. Philos Trans R Soc Lond B Biol Sci. 1990. PMID: 1969657 Review. - Control of cell proliferation by heparan sulfate and heparin-binding growth factors.
Vlodavsky I, Miao HQ, Atzmon R, Levi E, Zimmermann J, Bar-Shavit R, Peretz T, Ben-Sasson SA. Vlodavsky I, et al. Thromb Haemost. 1995 Jul;74(1):534-40. Thromb Haemost. 1995. PMID: 8578521 Review. No abstract available.
Cited by
- Amphiregulin Exerts Proangiogenic Effects in Developing Murine Lungs.
Thapa S, Shankar N, Shrestha AK, Civunigunta M, Gaikwad AS, Shivanna B. Thapa S, et al. Antioxidants (Basel). 2024 Jan 8;13(1):78. doi: 10.3390/antiox13010078. Antioxidants (Basel). 2024. PMID: 38247502 Free PMC article. - Bone Marrow CD11c+ Cell-Derived Amphiregulin Promotes Pulmonary Fibrosis.
Ding L, Liu T, Wu Z, Hu B, Nakashima T, Ullenbruch M, Gonzalez De Los Santos F, Phan SH. Ding L, et al. J Immunol. 2016 Jul 1;197(1):303-12. doi: 10.4049/jimmunol.1502479. Epub 2016 May 20. J Immunol. 2016. PMID: 27206766 Free PMC article. - LepR+ niche cell-derived AREG compromises hematopoietic stem cell maintenance under conditions of DNA repair deficiency and aging.
Wu L, Lin Q, Chatla S, Amarachintha S, Wilson AF, Atale N, Gao ZJ, Joseph J, Wolff EV, Du W. Wu L, et al. Blood. 2023 Nov 2;142(18):1529-1542. doi: 10.1182/blood.2022018212. Blood. 2023. PMID: 37584437 Free PMC article. - The emerging roles of eosinophils in mucosal homeostasis.
Shah K, Ignacio A, McCoy KD, Harris NL. Shah K, et al. Mucosal Immunol. 2020 Jul;13(4):574-583. doi: 10.1038/s41385-020-0281-y. Epub 2020 Mar 10. Mucosal Immunol. 2020. PMID: 32157190 Review. - Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.
Kersh AE, Ng S, Chang YM, Sasaki M, Thomas SN, Kissick HT, Lesinski GB, Kudchadkar RR, Waller EK, Pollack BP. Kersh AE, et al. J Clin Pharmacol. 2018 Jan;58(1):7-24. doi: 10.1002/jcph.1028. Epub 2017 Nov 14. J Clin Pharmacol. 2018. PMID: 29136276 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials